These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

193 related articles for article (PubMed ID: 21820033)

  • 21. Ubiquitin-like protein modifications in prostate and breast cancer.
    Wu F; Mo YY
    Front Biosci; 2007 Jan; 12():700-11. PubMed ID: 17127330
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Androgen receptor regulates expression of the MUC1-C oncoprotein in human prostate cancer cells.
    Rajabi H; Joshi MD; Jin C; Ahmad R; Kufe D
    Prostate; 2011 Sep; 71(12):1299-308. PubMed ID: 21308711
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Dynamic SUMOylation is linked to the activity cycles of androgen receptor in the cell nucleus.
    Rytinki M; Kaikkonen S; Sutinen P; Paakinaho V; Rahkama V; Palvimo JJ
    Mol Cell Biol; 2012 Oct; 32(20):4195-205. PubMed ID: 22890844
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Involvement of transcription factor Sp1 in quercetin-mediated inhibitory effect on the androgen receptor in human prostate cancer cells.
    Yuan H; Gong A; Young CY
    Carcinogenesis; 2005 Apr; 26(4):793-801. PubMed ID: 15661808
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Regulatory processes affecting androgen receptor expression, stability, and function: potential targets to treat hormone-refractory prostate cancer.
    Reddy GP; Barrack ER; Dou QP; Menon M; Pelley R; Sarkar FH; Sheng S
    J Cell Biochem; 2006 Aug; 98(6):1408-23. PubMed ID: 16619263
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Resveratrol down-regulates the androgen receptor at the post-translational level in prostate cancer cells.
    Harada N; Murata Y; Yamaji R; Miura T; Inui H; Nakano Y
    J Nutr Sci Vitaminol (Tokyo); 2007 Dec; 53(6):556-60. PubMed ID: 18202547
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Differential posttranscriptional regulation of androgen receptor gene expression by androgen in prostate and breast cancer cells.
    Yeap BB; Krueger RG; Leedman PJ
    Endocrinology; 1999 Jul; 140(7):3282-91. PubMed ID: 10385425
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [The concept and mechanisms of castration-resistant prostate cancer].
    Naito S; Shiota M
    Nihon Rinsho; 2014 Dec; 72(12):2090-4. PubMed ID: 25518339
    [TBL] [Abstract][Full Text] [Related]  

  • 29. A novel androgen receptor-binding element modulates Cdc6 transcription in prostate cancer cells during cell-cycle progression.
    Jin F; Fondell JD
    Nucleic Acids Res; 2009 Aug; 37(14):4826-38. PubMed ID: 19520769
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Non-genomic action of resveratrol on androgen and oestrogen receptors in prostate cancer: modulation of the phosphoinositide 3-kinase pathway.
    Benitez DA; Pozo-Guisado E; Clementi M; Castellón E; Fernandez-Salguero PM
    Br J Cancer; 2007 May; 96(10):1595-604. PubMed ID: 17486135
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Inhibition of androgen receptor activity by histone deacetylase 4 through receptor SUMOylation.
    Yang Y; Tse AK; Li P; Ma Q; Xiang S; Nicosia SV; Seto E; Zhang X; Bai W
    Oncogene; 2011 May; 30(19):2207-18. PubMed ID: 21242980
    [TBL] [Abstract][Full Text] [Related]  

  • 32. TRIM68 regulates ligand-dependent transcription of androgen receptor in prostate cancer cells.
    Miyajima N; Maruyama S; Bohgaki M; Kano S; Shigemura M; Shinohara N; Nonomura K; Hatakeyama S
    Cancer Res; 2008 May; 68(9):3486-94. PubMed ID: 18451177
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Increased androgen receptor transcription: a cause of castration-resistant prostate cancer and a possible therapeutic target.
    Shiota M; Yokomizo A; Naito S
    J Mol Endocrinol; 2011 Aug; 47(1):R25-41. PubMed ID: 21504942
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Post-Translational Modifications That Drive Prostate Cancer Progression.
    Samaržija I
    Biomolecules; 2021 Feb; 11(2):. PubMed ID: 33572160
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Prostaglandin 15d-PGJ(2) inhibits androgen receptor signaling in prostate cancer cells.
    Kaikkonen S; Paakinaho V; Sutinen P; Levonen AL; Palvimo JJ
    Mol Endocrinol; 2013 Feb; 27(2):212-23. PubMed ID: 23192983
    [TBL] [Abstract][Full Text] [Related]  

  • 36. MLL5, a histone modifying enzyme, regulates androgen receptor activity in prostate cancer cells by recruiting co-regulators, HCF1 and SET1.
    Lee KH; Kim BC; Jeong CW; Ku JH; Kim HH; Kwak C
    BMB Rep; 2020 Dec; 53(12):634-639. PubMed ID: 33050986
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Trihydrophobin 1 attenuates androgen signal transduction through promoting androgen receptor degradation.
    Yang Y; Zou W; Kong X; Wang H; Zong H; Jiang J; Wang Y; Hong Y; Chi Y; Xie J; Gu J
    J Cell Biochem; 2010 Apr; 109(5):1013-24. PubMed ID: 20069563
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Regulation of androgen receptor and prostate cancer growth by cyclin-dependent kinase 5.
    Hsu FN; Chen MC; Chiang MC; Lin E; Lee YT; Huang PH; Lee GS; Lin H
    J Biol Chem; 2011 Sep; 286(38):33141-9. PubMed ID: 21799006
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Locus-wide chromatin remodeling and enhanced androgen receptor-mediated transcription in recurrent prostate tumor cells.
    Jia L; Shen HC; Wantroba M; Khalid O; Liang G; Wang Q; Gentzschein E; Pinski JK; Stanczyk FZ; Jones PA; Coetzee GA
    Mol Cell Biol; 2006 Oct; 26(19):7331-41. PubMed ID: 16980632
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Phosphorylation/dephosphorylation of androgen receptor as a determinant of androgen agonistic or antagonistic activity.
    Wang LG; Liu XM; Kreis W; Budman DR
    Biochem Biophys Res Commun; 1999 May; 259(1):21-8. PubMed ID: 10334909
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.